Lazar, 2007 - Google Patents
Validation of API Manufacturing Operations: Impact of Q7ALazar, 2007
- Document ID
- 5468168443911373908
- Author
- Lazar M
- Publication year
- Publication venue
- Journal of validation technology
External Links
Snippet
Although in theory, validation of Active Pharmaceutical Ingredients (APIs) may be the same as validation for dosage forms, in actual application they are not the same. The differences arise from the differences that exist between APIs and dosage forms in practicality. From the …
- 238000010200 validation analysis 0 title abstract description 116
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/06—Resources, workflows, human or project management, e.g. organising, planning, scheduling or allocating time, human or machine resources; Enterprise planning; Organisational models
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/10—Office automation, e.g. computer aided management of electronic mail or groupware; Time management, e.g. calendars, reminders, meetings or time accounting
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
World Health Organization | Quality assurance of pharmaceuticals: a compendium of guidelines and related materials. Good manufacturing practices and inspection | |
Munro | ICH Q7 good manufacturing practice guide for active pharmaceutical ingredients (APIs) | |
Bennett et al. | Pharmaceutical production: an engineering guide | |
Chaudhari et al. | A review on good manufacturing practice (GMP) for medicinal products | |
Sahoo et al. | World Health Organization and International Council for Harmonization guidelines for “Good Manufacturing Practices” | |
Lazar | Validation of API Manufacturing Operations: Impact of Q7A | |
Durivage | The Certified Pharmaceutical GMP Professional Handbook | |
World Health Organization | Quality Assurance of Pharmaceuticals: A Compendium of Guidelines and Related Materials. Good manufacturing practices and inspection | |
Huynh‐Ba | Good Manufacturing Practices (GMPs) and the Quality Systems | |
Scheme | Guide to good manufacturing practice for medicinal products Part I | |
Chidambaram et al. | Good laboratory practice | |
Eggert et al. | Conducting stability studies during development to ensure successful regulatory approval | |
Silverstein | Pharmaceutical excipient good manufacturing practices | |
De Decker et al. | The good laboratory practice and good clinical practice requirements for the production of radiopharmaceuticals in clinical research | |
Harris | Good manufacturing practices (GMP) and related FDA guidelines | |
Scheme | Guide to Good Manufacturing Practice for Medicinal Products | |
Schedule | Ministry of health and family welfare | |
Dong et al. | WHO GUIDELINES ON THE TRANSFER OF TECHNOLOGY PHARMACEUTICAL MANUFACTURING | |
Fry et al. | Records and Reports | |
Vander Zwan et al. | Quality of Active PHarmaceutical Ingredients | |
Linders et al. | Development of a Risk Management System for Consumables Used in Biopharmaceutical Manufacturing | |
Zephrani | Production and Process Controls | |
Dedeepya | A BOOK OF ANNUAL PRODUCT QUALITY REVIEW FOR ACTIVE PHARMACEUTICAL INGREDIENTS AND ITS COMPARISON BETWEEN THE USA & EUROPE REGULATORY ASPECTS | |
Scientific | Records and Reports | |
Fry et al. | 1. PURPOSE OF RECORDS AND REPORTS |